LV12449A - Udens suspensija nazalai lietosanai - Google Patents

Udens suspensija nazalai lietosanai

Info

Publication number
LV12449A
LV12449A LV990109A LV990109A LV12449A LV 12449 A LV12449 A LV 12449A LV 990109 A LV990109 A LV 990109A LV 990109 A LV990109 A LV 990109A LV 12449 A LV12449 A LV 12449A
Authority
LV
Latvia
Prior art keywords
suspension
loteprednol etabonate
water suspension
nasal use
dermal
Prior art date
Application number
LV990109A
Other languages
English (en)
Other versions
LV12449B (lv
Inventor
Koji Doi
Original Assignee
Bodor Nicholas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Nicholas filed Critical Bodor Nicholas
Publication of LV12449A publication Critical patent/LV12449A/lv
Publication of LV12449B publication Critical patent/LV12449B/lv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
LVP-99-109A 1997-01-16 1999-07-15 Ūdens suspensija nazālai lietošanai LV12449B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1966497 1997-01-16
PCT/JP1998/000108 WO1998031343A2 (en) 1997-01-16 1998-01-14 Aqueous suspension for nasal administration of loteprednol

Publications (2)

Publication Number Publication Date
LV12449A true LV12449A (lv) 2000-04-20
LV12449B LV12449B (lv) 2000-09-20

Family

ID=12005518

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-109A LV12449B (lv) 1997-01-16 1999-07-15 Ūdens suspensija nazālai lietošanai

Country Status (33)

Country Link
US (1) US6368616B1 (lv)
EP (1) EP0973501B1 (lv)
KR (1) KR100471708B1 (lv)
CN (1) CN1126535C (lv)
AR (1) AR011773A1 (lv)
AT (1) ATE249205T1 (lv)
AU (1) AU730953C (lv)
BR (1) BR9806771A (lv)
CA (1) CA2278025C (lv)
CZ (1) CZ294919B6 (lv)
DE (1) DE69818026T2 (lv)
DK (1) DK0973501T3 (lv)
EA (1) EA001775B1 (lv)
ES (1) ES2206880T3 (lv)
HK (1) HK1026138A1 (lv)
HU (1) HU226613B1 (lv)
ID (1) ID21892A (lv)
IL (1) IL130979A0 (lv)
LT (1) LT4677B (lv)
LV (1) LV12449B (lv)
MX (1) MXPA99006628A (lv)
NO (1) NO324619B1 (lv)
NZ (2) NZ509908A (lv)
PL (1) PL190753B1 (lv)
PT (1) PT973501E (lv)
RS (1) RS49701B (lv)
SI (1) SI20057A (lv)
SK (1) SK283164B6 (lv)
TR (1) TR199901663T2 (lv)
TW (1) TW503113B (lv)
UA (1) UA52722C2 (lv)
WO (1) WO1998031343A2 (lv)
ZA (1) ZA98303B (lv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
DE69932144T8 (de) * 1998-08-26 2007-10-04 Teijin Ltd. Pulverförmige pernasale mittel
DE19947235A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
US6565832B1 (en) * 2000-01-31 2003-05-20 Schering-Plough Healthcare Products, Inc. Spray composition with reduced dripping
ATE526973T1 (de) * 2001-06-18 2011-10-15 Noven Pharma Verbesserte arzneimittelabgabe in transdermalen systemen
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
DE602004008083T2 (de) * 2003-06-19 2008-04-24 Nicholas S. Gainsville Bodor Verstärkung der aktivität und/oder wirkdauer von ausgewählten entzündungshemmenden steroiden
KR20060032596A (ko) * 2003-06-19 2006-04-17 니콜라스 에스. 보도 국부 또는 다른 국소 투여를 위한 연성 항염증스테로이드의 활성 및/또는 작용기간의 증진
US20050095205A1 (en) * 2003-10-31 2005-05-05 Ramesh Krishnamoorthy Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
WO2005094836A2 (en) 2004-03-25 2005-10-13 Bausch & Lomb Incorporated Use of loteprednol etabonate for the treatment of dry eye
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007058935A2 (en) * 2005-11-14 2007-05-24 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US7687484B2 (en) * 2006-05-25 2010-03-30 Bodor Nicholas S Transporter enhanced corticosteroid activity
US7691811B2 (en) * 2006-05-25 2010-04-06 Bodor Nicholas S Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
AU2012312816A1 (en) 2011-09-22 2014-04-24 Bausch & Lomb Incorporated Ophthalmic gel compositions
TWI762706B (zh) 2017-08-24 2022-05-01 丹麥商諾佛 儂迪克股份有限公司 Glp-1組成物及其用途
BR112022013795A2 (pt) 2020-02-18 2022-09-13 Novo Nordisk As Composição farmacêutica líquida, e, kit

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
EP0709099A3 (en) * 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
KR100508227B1 (ko) 1997-03-14 2006-03-23 센주 세이야꾸 가부시키가이샤 로테프레드놀에타보네이트수성현탁액

Also Published As

Publication number Publication date
AU730953B2 (en) 2001-03-22
EP0973501A2 (en) 2000-01-26
LT99100A (en) 2000-02-25
ATE249205T1 (de) 2003-09-15
SI20057A (sl) 2000-04-30
WO1998031343A3 (en) 1998-09-17
WO1998031343A2 (en) 1998-07-23
HUP0002473A2 (hu) 2000-12-28
PL190753B1 (pl) 2006-01-31
EP0973501B1 (en) 2003-09-10
AR011773A1 (es) 2000-09-13
NZ336990A (en) 2001-03-30
KR100471708B1 (ko) 2005-03-07
RS49701B (sr) 2007-12-31
HUP0002473A3 (en) 2001-01-29
KR20000070214A (ko) 2000-11-25
DK0973501T3 (da) 2004-01-19
BR9806771A (pt) 2000-05-16
CN1250370A (zh) 2000-04-12
LT4677B (lt) 2000-07-25
EA001775B1 (ru) 2001-08-27
SK94899A3 (en) 2000-05-16
YU36199A (sh) 2002-09-19
CA2278025A1 (en) 1998-07-23
LV12449B (lv) 2000-09-20
AU730953C (en) 2002-02-07
US6368616B1 (en) 2002-04-09
CZ237499A3 (cs) 2000-01-12
ID21892A (id) 1999-08-05
HK1026138A1 (en) 2000-12-08
NZ509908A (en) 2004-12-24
ES2206880T3 (es) 2004-05-16
AU5495298A (en) 1998-08-07
NO993453L (no) 1999-07-13
DE69818026D1 (de) 2003-10-16
EA199900659A1 (ru) 2000-02-28
TW503113B (en) 2002-09-21
TR199901663T2 (xx) 1999-09-21
PT973501E (pt) 2004-02-27
DE69818026T2 (de) 2004-07-08
IL130979A0 (en) 2001-01-28
CN1126535C (zh) 2003-11-05
SK283164B6 (sk) 2003-03-04
ZA98303B (en) 1998-07-20
UA52722C2 (uk) 2003-01-15
NO993453D0 (no) 1999-07-13
CA2278025C (en) 2005-09-06
HU226613B1 (en) 2009-04-28
PL334614A1 (en) 2000-03-13
NO324619B1 (no) 2007-11-26
CZ294919B6 (cs) 2005-04-13
MXPA99006628A (es) 2005-01-10

Similar Documents

Publication Publication Date Title
LV12449A (lv) Udens suspensija nazalai lietosanai
DK0814782T3 (da) Farmaceutisk præparat stabiliseret med et basisk middel
DE60015851D1 (de) Atemmaske mit Dichtung
NO20022201L (no) Lösninger inneholdende Epinastin
CY1108593T1 (el) Συμπυκνωμενο υδατικο διαλυμα αμβροξολης
WO2004045453A3 (en) Absorbent neck shield
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
CA2411582A1 (en) Method for increasing the antioxidative potential of selenium-containing aqueous solutions
ATE254851T1 (de) Iod-herstellungszusammensetzung
NO20005281D0 (no) Meget rene vandige hydrogenperoksidoppløsninger, fremgangsmÕte for fremstilling derav samt anvendelse av oppløsningene
CA2361929A1 (en) Liquid deodorant
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
JP2000034347A5 (lv)
ATE326215T1 (de) Verwendung einer wässrigen lösung oder suspension zum heilen des hornhautepithels
CN213123740U (zh) 一种反扣式义甲固定带
PT1330246E (pt) Utilizacao de derivados do acido hidroxieicosatetraenoico em cirurgia intraocular
GB9807491D0 (en) An aqueous solution
AU2002100363A4 (en) Snore no more
JPS5448745A (en) Preparation of n-2-fluorenesulfonylamino acid
WO2002034246A3 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery
KR20000017673U (ko) 지압봉을 부착한 팬티
Happle Morsicatio linguarum as a Lapsus linguae: A Linguistic Poem